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Human milk contains a high concentration of indigestible oligosaccharides, which likely
mediated the coevolution of the nursing infant with its gut microbiome. Specifically,
Bifidobacterium longum subsp. infantis (B. infantis) often colonizes the infant gut and
utilizes these human milk oligosaccharides (HMOs) to enrich their abundance. In this
study, the physiology and mechanisms underlying B. infantis utilization of two HMO
isomers lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT) was investigated in
addition to their carbohydrate constituents. Both LNT and LNnT utilization induced a
significant shift in the ratio of secreted acetate to lactate (1.7–2.0) in contrast to the
catabolism of their component carbohydrates (∼1.5). Inefficient metabolism of LNnT
prompts B. infantis to shunt carbon toward formic acid and ethanol secretion. The
global transcriptome presents genomic features differentially expressed to catabolize
these two HMO species that vary by a single glycosidic linkage. Furthermore, a
measure of strain-level variation exists between B. infantis isolates. Regardless of strain,
inefficient HMO metabolism induces the metabolic shift toward formic acid and ethanol
production. Furthermore, bifidobacterial metabolites reduced LPS-induced inflammation
in a cell culture model. Thus, differential metabolism of milk glycans potentially drives the
emergent physiology of host-microbial interactions to impact infant health.
Keywords: bifidobacteria, human milk oligosaccharides, lacto-N-tetraose, lacto-N-neotetraose, host-microbial
interactions, microbiota
INTRODUCTION
Breastfeeding is critical for infant development and health in the absence of formula milk
substitutes. Human milk contains a high concentration of indigestible oligosaccharides, as well
as other nutritive molecules that promote growth experienced early in life (1–5). Human milk
oligosaccharides (HMOs), are indigestible carbohydrates soluble in humanmilk, and are composed
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of five monosaccharides: D-glucose (Glc), D-galactose
(Gal), N-acetylglucosamine (GlcNAc), L-fucose (Fuc), and
N-acetylneuraminic acid (Neu5Ac or sialic acid) with a
varying degree of polymerization and branching (6–9). These
oligosaccharides are not directly metabolized by the infant;
however, commensal bifidobacteria have coevolved within the
nursing infant gut to utilize HMO (10, 11).
Bifidobacterium longum subsp. infantis (B. infantis) colonizes
the nursing infant and is typically overrepresented within
the infant gut microbiome (12–15). The B. infantis genome
encodes an array of glycosyl hydrolases, oligosaccharide
transporters, and catabolic enzymes that enable HMO
utilization (10, 16–19). Both glycosyl hydrolases and
membrane-spanning transporters feed milk oligosaccharides
and their derivatives into the bifidobacterial fructose-6-
phosphate phosphoketolase (F6PPK) central fermentative
pathway. The F6PPK is believed to be unique to the genus
Bifidobacterium, which generates ATP from hexoses via
substrate-level phosphorylation resulting in the secretion
of endproducts to recycle co-factors (20–23). Bifidobacteria
initially converts one mole of fructose-6-phosphate to one
mole of erythrose 4-phosphate and one mole of acetyl-
phosphate via F6PPK (EC 4.1.2.22). A transaldolase (EC
2.2.1.2) and transketolase (EC 2.2.1.1) converts erythrose
4-phosphate and one mole of fructose-6-phosphate to two
moles of xylulose-5-phosphate, which are converted into two
moles of acetyl-phosphate and glyceraldehyde 3-phosphate via
xylulose-5-phosphate phosphoketolase activity (EC 4.1.2.9).
Acetyl-phosphate is dephosphorylated into acetate by an
acetate kinase (EC 2.7.2.1), accompanied by a single ATP per
acetyl-phosphate (24). In addition, glyceraldehyde 3-phosphate
is oxidized to pyruvate accompanied by the production of
a single ATP. Pyruvate is converted to lactate by lactate
dehydrogenase (EC 1.1.1.27) along with recycling NAD+
from NADH (25). For every 2 moles of hexose entering the
F6PPK pathway, 3 moles of acetate and 2 moles of lactate
are produced (i.e., ratio of 1.5). Based on transcriptomic
evidence, it is likely that B. infantis catabolizes HMO-derived
monosaccharides through the F6PPK pathway to generate
ATP (26). This potentially links bifidobacterial physiology (i.e.,
flux through the F6PPK pathway) with infant nutritional and
health outcomes as B. infantis benefits their developing host
(27, 28).
In general, all B. infantis strains examined to date efficiently
utilizes HMOs pooled from several donor mothers with
the exception of one (29–34). The tetrasaccharides lacto-N-
tetraose (LNT) and lacto-N-neotetraose (LNnT) are highly
abundant oligosaccharides secreted in human milk (2, 6).
LNT (Galβ1-3GlcNAcβ1-3Galβ1-4Glc) is classified as a type I
HMO, which incorporates lactosyl coupled to a lacto-N-biose
(LNB) (Galβ1-3GlcNAc) residue. In contrast, LNnT (Galβ1-
4GlcNAcβ1-3Galβ1-4Glc) is an isomer of LNT and classified
as a type II oligosaccharide, linking the terminal lactosyl with
N-acetyllactosamine (LacNAc) (Galβ1-4GlcNAc). These isomers
are identical aside from a sole glycosidic linkage (i.e., β1-3 vs.
β1-4) thus leading to the hypothesis that this structural variation
is responsible for differential phenotypes in bifidobacterial
utilization of these major HMOs.
MATERIALS AND METHODS
Bacterial Strains and Propagation
Bacterial strains used in this study are summarized in
Table 1. Bifidobacterial strains were propagated in De Man
Rogosa Sharp (MRS, Oxoid, Hampshire, England) medium
supplemented with 0.05% (wt/v) L-cysteine hydrochloride
(Sigma-Aldrich, St. Louis, MO) (35) at 37◦C under anaerobic
conditions (Coy Laboratory Products, Grass Lake, MI). Bacterial
strains were routinely verified using the bifidobacterial-specific
phosphoketolase assay (36) and bifidobacterial-specific PCR
targeting the 16S rRNA gene sequence using the previously
developed Bif164-F (5′-GGGTGGTAATGCCGGATG-3′) and
Bif662-R 5′-CCACCGTTACACCGGGAA-3′) (37). In addition,
the PCR-based Bifidobacterium longum/infantis ratio analysis
(BLIR) was performed to verify subspecies as previously
described (38).
Microplate Growth Assay
In order to evaluate growth phenotypes in a 96-well format,
overnight cultures were inoculated 1% (v/v) to modified
MRS media (mMRS; a defined carbohydrate substrate and
no acetate). Carbohydrate substrates used in this study
include glucose (Sigma-Aldrich Co. St. Louis, MO), galactose
(Sigma-Aldrich Co. St. Louis, MO), lactose (Sigma-Aldrich
Co. St. Louis, MO), L-fucose (Sigma-Aldrich Co. St. Louis,
MO), N-acetylglucosamine (GlcNAc) (Tokyo Chemical Industry
Co, Tokyo Japan), lacto-N-tetraose (LNT) (Elicityl-oligotech,
Crolles, France), and lacto-N-neotetraose (LNnT) (Elicityl-
oligotech, Crolles, France) at a final concentration of 2%
(wt/v) as the sole carbon source. Carbohydrate sources were
incorporated into culture media in non-limiting concentrations.
The growth assay was conducted anaerobically at 37◦C for
48 h by assessing optical density at 600 nm (OD600 nm) in
an automated PowerWave HT microplate spectrophotometer
(BioTek Instruments, Inc. Winooski, VT) placed within the
anaerobic chamber. Each strain was evaluated in biological
triplicates with three technical replicates. Inoculated mMRS
media in the absence of carbohydrate substrates served as the
negative control. Bacterial growth kinetics were calculated using
Wolfram Mathematica 10.3 Student Edition with the equation
below as described in Dai et al. (39).
∆OD (t) = 1ODasym{
1
1+ exp
[
ktc− t
] −
1
1+ exp
[
ktc
] }
TABLE 1 | List of strains used in this studya.
Strain Species Origin
ATCC 15697 B. longum subsp. infantis Human infant feces
UMA299 B. longum subsp. infantis Human infant feces
UMA300 B. longum subsp. infantis Human infant feces
UMA301 B. longum subsp. infantis Human infant feces
aUMA, University of Massachusetts Amherst Culture Collection; ATCC, American Type
Culture Collection.
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1ODasym is the growth level at stationary phase with k
representing the growth rate and tc is the inflection point
indicating the time to reach the highest growth rate.
Characterization of Microbial Metabolic
Endproducts
Endproducts from bacterial fermentation were quantitated by
HPLC. Bacterial strains were initially propagated as described
above. Cell-free supernatants from microplate growths were
obtained at early stationary phase and filtered through a 0.22µm
filter (Sartorius Corp, Bohemia, NY) following centrifugation
and stored at −20◦C until further analysis. Organic acids were
quantified using a Schimadzu HPLC system equipped with
a Refractive Index Detector 20A, (Schimadzu Corp., Kyoto,
Japan). Separation was carried out using an Aminex HPX-
87H column (7.8mm ID × 300mm, Bio Rad Laboratories,
Hercules, CA) at 30◦C in a mobile phase of 5mM H2SO4 at flow
rate of 0.6 ml/min with 20 µl of injection volume. Standards
including organic acids (i.e., acetic acid, lactic acid, formic acid),
ethanol, and carbohydrates (i.e., glucose, galactose, lactose, and
GlcNAc) were acquired from Sigma-Aldrich Co. (St. Louis, MO).
Metabolite concentrations were calculated from standard curves
derived from external standards for six concentrations (0.5, 1,
5, 10, 20, and 50mM). Metabolite profiling was carried out in
triplicate and each measurement was performed in duplicate.
The metabolite profiling for each strain subsisting on the
panel of carbohydrates were analyzed using MetaboAnalyst 3.0
(http://www.metaboanalyst.ca) (40). The sugar consumption in
percentages was calculated by dividing the amount of mono- and
di-saccharide consumed after fermentation by the concentration
of carbohydrate source prior to fermentation. The carbon
recovery in percentages was calculated by dividing the total
amount of carbon recovered in the metabolites by the total
amount of carbon present in pre-fermentation minus total
carbon of carbohydrate source after fermentation.
Quantitative Real-Time PCR Analysis
B. infantis gene expression was performed by quantitative real-
time PCR (qRT-PCR) on a relative basis. One ml samples
were harvested at mid-exponential phase (OD600 nm ∼ 0.4–
0.6 varied depending on carbohydrate source), pelleted at
12,000 × g for 2min, and stored in 1ml Ambion RNAlater
(Life Technologies, Carlsbad, CA). RNA extraction and cDNA
conversion was performed as previously described (26). Briefly,
samples were centrifuged at 12,000 × g for 2min to collect
the cell pellet. The pellet was washed twice with PBS buffer
to remove residual RNAlater and centrifuged at 12,000 × g
for 2min. Total RNA was extracted using Ambion RNAqeous-
Mini kit (LifeTechnologies, Carlsbad, CA) according to the
manufacturer’s instructions. Cells suspended in lysis buffer were
transferred to the Lysing Matrix E tubes (MP Biomedicals
LLC, Solon, Ohio) to disrupt cell walls through beadbeating
at 5.5 m/s for 30 s twice using FastPrep 24 bead beader (MP
Biomedicals, Santa Ana, CA). Total RNA was eluted in 50 µl of
EB solution and immediately subjected to DNase treatment with
the Ambion Turbo DNA-free (Invitrogen, Vilnius, Lithuania)
using 1 µl of DNase I for 30min. Subsequently, total RNA
was converted to cDNA using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA)
according to the manufacturer’s instructions. The resultant
cDNA was quantified by a Nanodrop 2000 Spectrophotometer
(Thermo Fisher Scientific Inc., Agawam, MA). The qRT-
PCR was performed on a 7500 Fast Real-Time PCR System
(Applied Biosystems, Singapore) with PowerUP SYBR Green
Master Mix (Applied Biosystems, Foster City, CA) using 200
ng of input cDNA. The reaction conditions were informed
by manufacturer recommendations and optimized for the
specific target locus. qRT-PCR primers were designed using
the Primer3 software (Table S1; http://frodo.wi.mit.edu). The
gene Blon_0393, encoding a cysteinyl-tRNA synthetase was used
as an endogenous control as previously (16, 41). Growth on
lactose (2% wt/v) served as the reference condition for gene
expression. Results were expressed as fold change relative to the
reference. These experiments were conducted in triplicates and
triplicate technical measurements were performed. Following
DNase treatment, the absence of genomic DNA was confirmed
using total RNA as template by qRT-PCR (i.e., endogenous
control reaction).
Statistical Analyses
The relationships between asymptotic OD600 nm, growth rates
and metabolites were characterized with principal components
analysis (PCA) and hierarchical clustering with Ward’s method
and Euclidean distances using R (R.3.4.0). The outliers
were determined according to their distance to the average
within biological replicates were omitted to maintain at least
biological triplicates. When no growth was observed in sugars,
the values were assigned as “0” for PCA function(prcomp)
analysis and PCA plots were drawn using ggbiplot in R.
Growth kinetics, metabolite concentrations, fold change in
gene expressions of cell culture for B. infantis ATCC 15697
were subjected to one-way analysis of variance (ANOVA)
and Tukey’s HSD test for multiple comparisons between
carbohydrate source. The fold change in gene expression for
B. infantis, growth kinetics, and metabolites between strains
were analyzed with two-way ANOVA. The simple effects and
main factor effects were determined with Tukey’s HSD test
for multiple comparisons of carbohydrate sources for the
same strain and between strains for a defined carbohydrate
source.
Bioinformatic Analysis of Transcriptome
Data
Transcriptomic data (i.e., raw reads) of B. infantis ATCC
15697 while growing on lactose, LNT, and LNnT was retrieved
from a previously performed RNA-seq study (26) publically
deposited in the NCBI Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo/) under the accession number
GSE58773 (and personal communication with Danielle Lemay).
This data was uploaded to the Massachusetts Green High
Performance Computing Cluster (MGHPCC) that was used for
all computational/statistical analyses unless specifically noted.
The RNA-seq reads were aligned to the reference B. longum
subsp. infantis ATCC 15697 genome (NC_011593.1). Coding
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regions of the ATCC 15697 genome were subjected to this
analysis. Total and unique gene reads aligning to a specific
genomic locus (i.e., locus tag), as well as calculated raw counts
was obtained for differential expression analysis.
Differential Gene Expression
In order to identify and quantify the magnitude of differentially
expressed genes, the R package DESeq2 was used to analyze the
raw count data (42). Genes with amean count<200 was removed
from analysis by pre-filtering. DESeq2 applies the Wald test for
statistical analysis. Adjusted p ≤ 0.05 were defined as statistically
significant.
Anti-inflammation Assay Performed in a
Cell Culture Model
Caco-2 cells (ATCC HTB 37) lines were routinely cultured
in High Glucose Dulbecco’s Modified Eagle Medium (DMEM)
(Corning, Manassas, VA) supplemented with NaHCO3 (Sigma-
Aldrich, St. Louis, MO), 1% non-essential amino acids (Gibco,
Dublin, Ireland), 100 U/ml penicillin-streptomycin (Gibco,
Dublin, Ireland), 10% (v/v) fetal bovine serum (Seradigm VWR,
Radnor, PA), and 7mMHEPES (Gibco, Dublin, Ireland). Caco-2
cells were routinely grown in 20-cm Petri plates and subcultured
at 80% confluence and maintained at 37◦C in a humidified
atmosphere of 5% (v/v) CO2 in air.
The cells were differentiated at passages 30–32 and collected
by dissociation of a 90% confluent stock culture with 0.25%
trypsin/EDTA (Gibco, Dublin, Ireland). For the inflammation
assay, Caco-2 cells were seeded in 24-well plate at a concentration
of 1–2 × 105 cells/cm2 and were differentiated for 17 days with
the medium changed every 2–3 days. Replicate supernatants
collected from B. infantis ATCC 15697 growing on lactose, LNT,
and LNnT were mixed in equal volume and added into the
DMEM at the final concentration of 15% (v/v). One hundred
microliter of acetic acid, lactic acid, and formic acid controls
were mixed with DMEM. Subsequently, media was added to
each well in triplicates and incubated at 37◦C in a 5% CO2
atmosphere for 2 h. For negative and positive controls, triplicates
were seededwith only DMEM.After incubation, 10µl of 5mg/ml
lipopolysaccharide (LPS, Sigma-Aldrich, St. Louis, MO) in PBS
was added into the wells and incubated for 24 h for treatments.
LPS alone was used for negative control. PBS alone served as the
carrier solution and a reference control. After incubation, the
cells were detached from the plate surface by incubation with
trypsin/EDTA, suspended in 500 µl of RNAlater solution and
stored at−80◦C until RNA extraction.
The relative gene expression of interleukin-8 (IL-8) linked
with LPS-induced inflammation expression was quantified
using qRT-PCR. Total RNA was extracted using the Ambion
RNAqeous-Total RNA extraction kit (Invitrogen, Vilnius,
Lithuania) according to the manufacturer’s instructions.
Cells suspended in lysis buffer were transferred to Lysing
Matrix D tubes specific for eukaryotic cell and tissues culture
(MP Biomedicals LLC, Solon, Ohio) and were subject to a
speed of 5.5 m/sec for 30 sec twice using the FastPrep 24
bead beader (MP Biomedicals, Santa Ana, CA). The total
RNA was eluted in 50 µl of EB solution and immediately
subjected to DNase treatment with the Ambion Turbo DNA-free
(Invitrogen, Vilnius, Lithuania) using 1 µl of DNase I for
half-hour. Total RNA was converted to cDNA using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Carlsbad, CA) according to manufacturer’s instructions.
The resultant cDNA was quantified in a Nanodrop 2000
Spectrophotometer (Thermo Fisher Scientific Inc., Agawam,
MA). The qRT-PCR analysis was performed using a 7500
Fast Real-Time PCR System (Applied Biosystems, Singapore)
with PowerUP SYBR Green Master Mix (Applied Biosystems,
Foster City, CA) using 200 ng of cDNA with primers GAPDH-
F (5′-GTCGCTGTTGAAGTCAGAGG-3′) and GAPDH-R
(5′-GAAACTGTGGCGTGATGG-3′) for endogenous control
and primers IL-8-F (5′-GACCACACTGCGCCAACAC-3′)
and IL-8-R (5′-CTTCTCCACAACCCTCTGCAC-3′) (43).
The PCR cycling conditions were applied as recommended
by the manufacturer and tailored specifically to the target
genes. Additional markers of inflammation were tested using
primers IL-10-F (5′-GGTTGCCAAGCCTTGTCTGA-3′),
IL-10-R (5′-AGGGAGTTCACATGCGCCT-3′) (44), and
TNF-α-F (5′-TCAACCTCCTCTCTGCCATC-3′), TNF-α-R
(5′-CCAAAGTACACCTGCCCAGA-3′) (45).
RESULTS
B. longum subsp. infantis Exhibits
Divergent Growth Phenotypes During
Utilization of the Milk Oligosaccharides
Lacto-N-tetraose and Lacto-N-neotetraose
In order to understand B. infantismetabolism of HMOs, the type
strain ATCC 15697 was subjected to growth on purified HMO
species and constituent mono- and di-saccharides. Accordingly,
B. infantis ATCC 15697 grew vigorously on lactose (OD600 nm,
asym = 1.27 ± 0.12, k = 0.56 ± 0.03 h−1) as well as galactose
(OD600 nm, asym = 1.20 ± 0.13, k = 0.61 ± 0.02 h−1) (Figure 1).
The HMO species LNT was utilized as a sole carbohydrate source
to a similar extent (OD600 nm, asym = 1.19± 0.24, k= 0.51± 0.02
h−1) as these two constituent residues (Figure 1). Interestingly,
the structural isomer LNnT promoted a more moderate growth
profile (OD600 nm, asym = 0.85 ± 0.09, k = 0.57 ± 0.04 h−1)
(p < 0.05) (Figure 1). The B. infantis type strain did not
grow on the HMO constituents GlcNAc and fucose as a sole
carbohydrate source. It is noteworthy that growth on glucose was
inconsistent in terms of final OD600 nm; therefore, a comparison
to the other carbohydrates was limited. The significant difference
between LNT and LNnT utilization (p< 0.05) suggests that these
HMOs are metabolized via differential mechanisms that vary in
efficiency (Figure 1A). Differences in growth rates between the
HMO species were not observed which indicates an equivalent
preference for LNT and LNnT (Figure 1B). B. infantis ATCC
15697 exhibited similar growth rates for lactose, galactose, and
LNnT (p > 0.05). Although growth efficiencies on galactose and
LNT are similar (Figure 1A), B. infantis ATCC 15697 prefers
galactose to LNT as indicated by growth rate (p < 0.05). In
aggregate, the single structural difference between LNT and
LNnT is directly linked to the efficiency by which B. infantis
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FIGURE 1 | B. longum subsp. infantis ATCC 15697 growth kinetics while utilizing milk carbohydrates. The final asymptotic OD600 nm (A) and growth rate (k, h
−1)
(B) of B. infantis ATCC15697 subsisting on mMRS medium containing 2% (wt/v) galactose (Gal), lactose (Lac), lacto-N-tetraose (LNT), or lacto-N-neotetraose (LNnT).
The growth kinetics was calculated with Wolfram Mathematica 10.3. The data depicts mean ± SD of three independent experiments. The single asterisk (*) indicates
the significant differences between carbohydrate utilizations evaluated by one-way ANOVA and Tukey’s multiple comparison (p < 0.05).
utilizes these HMO species. Previous studies indicate that ATCC
15697 grows on both LNT and LNnT to achieve aOD600 nm> 0.8,
however these studies did not report the specific asymptotic
growth (i.e., efficiency) or growth rate (i.e., preference) when
growing on these two HMO species (17, 26, 46, 47). Thus
it is significant that ATCC 15697 exhibits clear differences in
utilization between LNT and LNnT when accumulating biomass
to OD600 nm values>0.8.
Metabolic Endproducts Are Differentially
Secreted Dependent on the Milk
Oligosaccharide Substrate
Lacto-N-tetraose or Lacto-N-neotetraose
Fermentative endproducts were profiled to detail the metabolic
consequences of HMO carbohydrate flux through the F6PPK
pathway. During hexose fermentation, acetic acid and lactic acid
are typically secreted in a theoretical ratio of 1.5. In contrast,
formic acid production is not expected under most conditions
tested to date (20, 47). The absolute concentrations of lactic acid,
acetic acid, formic acid, ethanol, and the ratios between these
metabolites are depicted in Figure 2. B. infantis ATCC 15697
produces similar concentrations of lactic acid while growing
on galactose, lactose, and LNT (42.5 ± 5.7, 47.8 ± 5.7, and
46.5 ± 2.5mM respectively) (p > 0.05, Figure 2A). A much
lower lactic acid concentration, however, was secreted while
utilizing LNnT (29.5 ± 5.9mM) compared to the metabolism
of other carbohydrates (p < 0.05). Interestingly, formic acid
and ethanol concentrations were significantly higher while
growing on LNnT (16.3 ± 4.1 and 2.5 ± 1.1mM respectively).
This is contrasted with the relatively smaller concentrations
while growing on LNT, lactose, and galactose (p < 0.05,
Figures 2C,D).
LNT metabolism resulted in the highest concentration of
secreted acetic acid (84.8±4.4mM, Figure 2B) and significantly
differed from LNnT metabolism (p < 0.05). In general,
fermentative endproduct concentrations are expected to be
positively correlated with the final biomass (48), as more
carbohydrates processed by the F6PPK pathway results in more
organic acids secreted. Therefore, it is expected that lactic acid
and acetic acid concentrations will be higher when greater
biomass is achieved (47). However, acetic acid concentrations
while utilizing galactose, lactose, and LNnT did not significantly
differ from each other (p > 0.05). Overall, these data support the
hypothesis that B. infantis deploys a different mechanism while
utilizing LNnT than LNT.
The Ratio of Secreted Endproducts
Indicate an Alternative Pathway for
Lacto-N-neotetraose Metabolism
Bifidobacteria, including B. infantis, catabolize 2 moles hexose to
secrete 2 moles of lactic acid and 3 moles of acetic acid via the
F6PPK pathway (Figure 3). This theoretical yield (i.e., acetate:
lactate ratio of 1.5) was achieved during growth on galactose and
lactose (1.56 ± 0.01 and 1.58 ± 0.01, respectively, Figure 2E).
During HMOmetabolism, LNT and LNnT utilization shifted the
ratio toward greater acetic acid production (1.84± 0.01 and 2.08
± 0.14, respectively, p< 0.05, Figure 2E). This is likely due to the
deacetylation of the GlcNAc residue, at least in part. Notably this
ratio significantly diverges between LNT and LNnT utilization
with the latter experiencing a stronger shift (p < 0.05). If both
HMO isomers increased the relative proportion of acetic acid via
GlcNAc deacetylation, the higher ratio during LNnT metabolism
is due to either decreased lactic acid production and/or increased
acetic acid production from acetyl-CoA conversion.
LNnT metabolism was characterized by a significant increase
in formic acid and ethanol production despite lower biomass.
Accordingly, the ratio of formic acid to lactic acid was
significantly higher during LNnT metabolism (p < 0.05,
Figure 2F). Similarly, LNnT metabolism increased the formic
acid to acetic acid ratio significantly (p < 0.05, Figure 2G).
The theoretical formic acid to acetic acid ratio is 2:5 during
more than 50% conversion of acetyl-CoA to acetic acid
(25). This ratio was approached during LNnT metabolism
(Figure 2G). This means, in part, that pyruvate is shunted
toward acetyl-CoA resulting more formic acid and acetic acid
production rather than lactic acid. Accordingly, ethanol to
lactic acid ratio during LNnT fermentation differed significantly
from LNT, as well as the other carbohydrates (p < 0.05,
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FIGURE 2 | B. longum subsp. infantis ATCC 15697 fermentative endproducts while utilizing milk carbohydrates through the F6PPK pathway. Absolute concentrations
of lactic acid (A), acetic acid (B), formic acid (C), and ethanol (D). In addition, acetic acid to lactic acid ratio (E), formic acid to lactic acid ratio (F), formic acid to acetic
acid ratio (G), and ethanol to lactic acid ratio (H). All panels represent B. infantis ATCC15697 growing on mMRS medium containing 2% (wt/v) galactose (Gal), lactose
(Lac), lacto-N-tetraose (LNT), or lacto-N-neotetraose (LNnT). Averages from independent biological replicates (triplicate or more) are shown with bars representing
standard deviations of the means. The values for organic acid production are expressed in millimolar (mM) absolute concentration. A single asterisk (*) denotes
significant differences between metabolite production evaluated by one-way ANOVA and Tukey’s multiple comparison test (p < 0.05).
FIGURE 3 | Bifidobacterium longum subsp. infantis metabolic pathways for utilization of lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT) and their constituent
monosaccharides. LNT and LNnT translocate through the cell membrane facilitated by ABC transporters. Intracellular glycosyl hydrolases process HMO into
constituent monosaccharides to enter the central fermentative pathway. This pathway involves the characteristic fructose-6-phosphate phosphoketolase (F6PPK)
activity denoted in blue. Genes encoding intracellular metabolic enzymes are depicted next to arrows according to their locus tag in the ATCC 15697 genome. Solid
arrows are direct conversions with dashed arrows depicting the sequential actions of multiple enzymes. Predicted catabolic operations that feed into the F6PPK
pathway and their corresponding products are denoted as purple. Stoichiometric coefficients of secreted metabolites, ATP, and NAD+ produced during metabolism
are labeled in red. Experimental observations depicted in Figures 1, 2 including stoichiometry are incorporated.
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Figure 2H). The theoretical ratio is 1:1 when 50% of acetyl-
coA is converted to ethanol. The higher ethanol to lactic
acid ratio in LNnT indicates that ethanol production occurs
for regenerating NAD+. The theoretical ratio has not been
reached (∼0.08), thus this explains that acetyl-CoA was mostly
converted to acetic acid rather than ethanol to increase ATP
production instead of NAD+ recycling. This indicates a clear
metabolic shift toward these endproducts while subsisting
on LNnT.
Oligosaccharide Transport Gene
Expression Remains Similar Regardless of
Lacto-N-tetraose and
Lacto-N-neotetraose Substrates
As with other bifidobacteria examined to date, B. infantis ATCC
15697 encodes several family 1 solute binding proteins (F1SBPs),
ATP-binding domains, and permeases that assemble into ABC
transporters with predicted affinity for oligosaccharides (10, 16,
49). The expression of four F1SBPs and their cognate ABC
permeases during LNT and LNnT utilization was evaluated
to test the hypothesis that transport contributes to the
differential metabolic phenotypes (Figures 4A,B). These F1SBPs
were previously identified to bind glycans that incorporate
HMO moieties (16). Three F1SBPs (Blon_0883, Blon_2344 and
Blon_2347) and four ABC permeases (Blon_2175, Blon_2176,
Blon_2345 and Blon_2346) were induced more than 2-fold
during the growth on LNT or LNnT as the sole carbon source
relative to lactose (p < 0.05). Only Blon_2347 expression
differed significantly between the metabolism of the two HMO
species (p < 0.05, Figure 4A). Interestingly, both LNT and
LNnT induced the F1SBP Blon_0883, although its adjacent
permease proteins Blon_0884 and Blon_0885 were not induced
(p > 0.05). Main effect analysis via two-way ANOVA indicates
that Blon_2347 exhibits the strongest induction among the four
F1SBP genes regardless of substrate (p < 0.05, Figure 4A).
Among the permeases, it is notable that the highest relative
expression occurred in transcription of Blon_2346, followed by
Blon_2345 (p< 0.05, Figure 3B). These genes are located in a 40-
kb catabolic cluster dedicated specifically to HMO metabolism
(10). This indicates that B. infantis deploys HMO cluster
transporters while utilizing both LNT and LNnT which differs
significantly from its corresponding component, lactose. The
differential metabolic phenotypes between LNT and LNnT are
not linked to the expression of these transport genes, indicating
that it is likely a function of intracellular catabolic operations.
B. infantis Upregulates
N-acetylglucosamine Metabolic Genes
While Utilizing Lacto-N-tetraose and
Lacto-N-neotetraose
During HMO hydrolysis, GlcNAc is liberated from the
oligosaccharide and likely subjected to deamination and
deacetylation before entering the F6PPK pathway (Figure 3).
This is catalyzed by GlcNAc-6-phosphate deacetylase (nagA;
Blon_0882, EC 3.5.1.25) and glucosamine-6-phosphate
isomerase/deaminase (nagB; Blon_0881, EC 3.5.99.6). Both
FIGURE 4 | ATCC 15697 gene expression while subsisting on milk
oligosaccharides as a sole carbon source. The x-axis represents gene locus
tags of Family 1 solute binding proteins (A), ABC permeases (B), and
GlcNAc-active genes (C). The y-axis depicts the fold changes in gene
expression relative to the control lactose as measured by qRT-PCR. LNT and
LNnT are denoted in purple and gray. The error bars show standard deviations
of three biological replicates except for LNnT. *p < 0.05 evaluated by one-way
ANOVA and Tukey’s multiple comparison.
Blon_0881 and Blon_0882 exhibited significant upregulation
while growing on LNT and LNnT relative to lactose (p < 0.05).
Specifically, LNT induced fold changes of 19.34 ± 3.21 and
21.84 ± 3.90 of Blon_0881 and Blon_0882 respectively, whereas
LNnT prompted a similar induction measured at 18.71 ± 5.43
and 20.61 ± 6.19 (Figure 4C). This upregulation is interpreted
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as consistent with GlcNAc catabolism providing evidence
that deacetylation occurs during LNT and LNnT utilization.
Significant differences in the expression of these GlcNAc genes
were not detected between LNT and LNnT metabolism. This
expression profile could reflect the growth rate similarity between
LNT and LNnT as depicted in Figure 1B.
The B. infantis Transcriptome Diverges
During Lacto-N-tetraose and
Lacto-N-neotetraose Metabolism
The B. infantis ATCC 15697 transcriptome while utilizing
HMOs was previously characterized by RNA-seq (26). Given the
differential metabolism observed in the current study, specific
pathways predicted to be relevant to LNT and LNnT utilization
were examined in greater depth according to differential gene
expression beyond normalized counts. Accordingly, raw reads
were retrieved and subjected to differential expression analysis
(i.e., 2-fold change) for HMO utilization cluster genes, galactose
catabolic genes (i.e., Leloir pathway), GlcNAc-related genes,
glycosyl hydrolases, and the F6PPK pathway as listed in Table S2.
Genes involved in galactose metabolism (Blon_2171,
Blon_2172, and Blon_2174) and adjacent ABC transporters
(Blon_2175, Blon_2176, and Blon_2177) are strongly
upregulated by both LNT and LNnT compared to lactose
(p < 0.05) (Figure 5). Moreover, LNnT prompted stronger
induction of these genes relative to LNT (p < 0.05). Similarly,
F1SBPs and permeases localized to the HMO utilization cluster
(i.e., Blon_2344-2352) were upregulated by both LNT and LNnT
relative to the lactose control (p< 0.05). In addition, Blon_2344,
Blon_2347, and Blon_2352 were significantly upregulated during
LNT fermentation when compared to LNnT (p< 0.05).
The GlcNAc utilization genes Blon_0881 (nagB) and
Blon_0882 (nagA) were significantly upregulated while
B. infantis utilizes both LNT and LNnT relative to lactose
(p < 0.05, Figure 5). However, there is no significant difference
between LNT and LNnT metabolism (p > 0.05). This is
consistent with the qRT-PCR gene expression analysis.
The key enzyme fructose-6-phosphate phosphoketolase (xfp,
Blon_1722) has been postulated to be highly expressed regardless
of carbohydrate substrate (26). Interestingly, F6PPK pathway
genes are downregulated by LNT relative to lactose and
LNnT (p < 0.05, Figure 5). In addition, LNnT showed strong
upregulation of those genes compared to lactose (p < 0.05),
except for Blon_1722, Blon_1096, and Blon_1368 that did
not significantly differ (p > 0.05). This is interesting as
the biomass and growth rate achieved with LNT or lactose
did not significantly differ (p > 0.05, Figure 1). Despite the
potential for greater flux through the central fermentative
pathway as per the transcriptome, LNnT prompted less biomass
production (p < 0.05). Furthermore, lactate dehydrogenase
(ldh; Blon_0840, EC 1.1.1.37), converts pyruvate to lactate to
recycle cofactors and was significantly induced by LNnT relative
to lactose and LNT (p < 0.05). The relationship between ldh
expression and LNnT inducing lower lactic acid concentrations
is unclear. This is potentially indicative of variation between
the physiological state of the cells during sample collection (i.e.,
FIGURE 5 | Relative gene expression within the global transcriptome depicted
as log2-fold change. The log2-fold change gene expression from independent
biological duplicates was performed from raw reads using the R package
DESeq2. The 2-fold change expressions were subjected to hierarchical
clustering using Euclidean distance and depicted as z-scores. Gene
annotations and predicted functions are reported in Table S2.
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mid-exponential or stationary phase). Accordingly, high levels
of lactic acid was observed at the beginning of fermentation of
oligofructose by B. animalis and replaced by formic acid at later
stages (50).
Interestingly, and potentially underlying differential
metabolism, acetate kinase (ack; Blon_1731, EC 2.7.2.1)
was more strongly upregulated while consuming LNnT relative
to lactose and LNT (p< 0.05). Acetate kinase catalyzes substrate-
level phosphorylation in the F6PPK pathway that is both
involved in conversion of phosphoketolase to acetyl-P and
conversion of acetyl-coA to acetate, and thus reflects relatively
higher acetic acid secretion during LNnT fermentation.
As LNnT utilization is characterized by increased formic
acid production, putative genes involved in this pathway were
interrogated. It is noteworthy that this metabolic process is
incompletely characterized in the bifidobacteria. Formate acetyl
transferase (Blon_1715, EC 2.3.1.54) and pyruvate formate
lyase (Blon_1714, EC 1.97.1.4) potentially converts pyruvate to
acetyl-coA and produces formic acid. Accordingly, Blon_1715
is highly expressed during LNnT utilization relative to lactose
and LNT (p < 0.05). Conversely, LNT metabolism is not
characterized by increased formic acid production and prompted
a downregulation of both Blon_1714 and Blon_1715 relative
to lactose and LNnT (p < 0.05). Although F6PPK genes were
upregulated by LNnT relative to lactose, the strongest change was
observed in formate acetyl transferase (2-fold change = 1.20).
Again, this is consistent with increased formic acid production
during LNnT metabolism to provide evidence that differential
phenotypes exhibited between LNnT and LNT is regulated at the
gene expression level, at least in part.
Twenty five key glycosyl hydrolases (GHs) were selected
for further analysis (Figure 5) (10, 17, 51). A total of 13
loci significantly differ between LNT and LNnT metabolism
(p < 0.05). Among β-galactosidases, Blon_2016 (GH family
42), and Blon_2334 (GH family 2) were downregulated during
LNT utilization relative to lactose and LNnT (p < 0.05). This is
interesting because Blon_2016 was shown to have specificity to
type I HMOs such as LNT (52) and Blon_2334 was shown to
be constitutively expressed in the utilization of pooled HMOs
and other complex oligosaccharides (26, 51). β-glucosidase
Blon_1905 was significantly upregulated by both LNT and LNnT
compared to lactose (p < 0.05) with expression during LNnT
growth significantly higher than LNT (p< 0.05).
Salient to general HMO metabolism, an α-L-fucosidase
Blon_0248 (GH family 29) was significantly upregulated by LNnT
compared to lactose and LNT (p < 0.05). Interestingly, another
GH 29 α-L-fucosidase (Blon_0426) is strongly upregulated by
LNT whereas it is downregulated by LNnT (p < 0.05). Other
fucosidases Blon_2335 and Blon_2336 were strongly upregulated
by LNT rather than LNnT (p < 0.05). The glycosyl hydrolases,
Blon_0625 and Blon_2460 were downregulated in both HMO
species compared to lactose, with a significantly stronger
downregulation observed in LNnT than LNT (p < 0.05).
Blon_2468, an endo-β-N-acetylglucosaminidase, which
generally releases N-glycans from human milk glycoproteins
was upregulated by LNT while it was downregulated by LNnT
(p< 0.05).
B. longum subsp. infantis Exhibits Growth
Phenotype Variance While Utilizing
Lacto-N-tetraose and Lacto-N-neotetraose
in a Strain-Dependent Manner
In order to evaluate potential phenotypic variation within
B. infantis, three strains in addition to ATCC 15697 were
subjected to growth on glucose, galactose, lactose, LNT, and
LNnT as a sole carbon source (Table S3). Both B. infantis
UMA299 and UMA300 utilized GlcNAc as a sole carbohydrate
substrate in contrast to ATCC 15697. None of the B. infantis
strains tested utilized fucose as a sole fermentative substrate.
UMA299 exhibited lower growth on LNT (OD600 nm, asym = 0.69
± 0.09, k= 0.57± 0.05 h−1) and LNnT (OD600 nm, asym = 0.71±
0.06, k= 0.68± 0.06 h−1) compared to constituent carbohydrate
residues within HMOs (p < 0.05, Table S3). This is significant,
as UMA299 does not utilize pooled HMOs efficiently in contrast
to other B. infantis strains (31). This is likely due to the absence
of two F1SBP transporter genes (Blon_2344 and Blon_2351)
in its HMO catabolic cluster (30). Interestingly, and despite
limited growth, UMA299 exhibited a higher preference for LNnT
with significantly lower growth rate on LNT (p < 0.05). In
addition, UMA299 exhibited a OD600 nm, asym of 0.42 ± 0.09 on
soluble GlcNAc with a growth rate of 0.16 ± 0.01 h−1 which
is significantly lower compared to other carbohydrates tested
(p< 0.05).
B. infantis UMA300 utilized LNnT efficiently (OD600 nm,
asym = 1.30 ± 0.12, k = 0.51±0.05 h−1) which is to the
same extent as LNT (OD600 nm, asym = 0.99 ± 0.20, k = 0.71
± 0.05 h−1). The strain utilized galactose to similar cellular
concentrations as LNT and LNnT and inefficiently utilizes
lactose and GlcNAc (Table S3). In terms of growth rate (k),
UMA300 experienced the highest rate on LNT and galactose
with a significantly lower growth rate on LNnT (p < 0.05).
This provides additional evidence that the two HMO species
are utilized by divergent mechanisms by B. infantis strains.
Despite achieving highest biomass concentrations on LNnT,
UMA300 preference as determined by growth rate did not vary
appreciably between LNnT and lactose (p > 0.05). UMA300
low growth rate on GlcNAc suggests that this aminosugar
is not preferred relative to the other carbohydrates tested
(p< 0.05).
In contrast to UMA300, B. infantis UMA301 exhibited
vigorous growth on lactose (OD600 nm, asym = 1.29 ± 0.05,
k= 0.56±0.05 h−1), followed by galactose (OD600 nm, asym = 1.22
± 0.05, k= 0.63± 0.06 h−1), and LNT (OD600 nm, asym = 1.01±
0.17, k= 0.44± 0.06 h−1) all of which does not differ significantly
(p > 0.05, Table S3). UMA301, however, achieved significantly
lower biomass concentrations on LNnT (OD600 nm, asym = 0.86
± 0.04, k = 0.40 ± 0.01 h−1) concomitant with a lower growth
rate. This suggests a clear preference for LNT rather than
LNnT between these two HMO tetrasaccharides. As with ATCC
15697, UMA301 does not utilize GlcNAc as a sole carbohydrate
source.
Consistent with the growth, ATCC 15697, UMA299, and
UMA301 consumed galactose and lactose >40%, whereas
UMA300 consumed lactose at 25% (p < 0.05, Figure S1A).
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Similarly, UMA299 consumed GlcNAc to a greater extent than
UMA300.
In order to determine phenotypic variation as a function of
carbohydrate source and B. infantis strain, principal component
analysis (PCA) and hierarchical clustering was performed.
This analysis incorporated both final asymptotic OD600 nm and
growth rate data for strains growing on individual substrates
(Figure 6). The first principal component (PC1) explains 40.8%
variation in OD600 nm, asym values, whereas PC2 captures
37.7% variation (Figure 6A). The scores of each component
grouped as strains clustered closely (i.e., within the normal
probability). This indicates that the growths are consistent among
biological replicates regardless of fermentative substrate. Arrows
oriented toward the same direction denote that growth on a
particular carbohydrate is correlated with that PC component
with the angle between arrows indicating a similar response
profile. LNT and galactose utilization vectors emanated toward
similar directions that is negatively correlated with both PCs
(Figure 6A). These two vectors aligned along PC1 where
ATCC 15697 and UMA301 growths clustered. UMA300 growth,
however, aligned positively with PC1 in the same direction as
the LNnT utilization vector. This indicates that UMA300 utilized
LNnT well relative to other carbohydrates and strains. This is
consistent with strain-dependent utilization, as UMA300 had a
higher final OD600 nm, asym during LNnT utilization compared
to other strains (Figure 7D). Interestingly, the LNnT and
lactose utilization vectors were oriented in opposing directions
suggesting utilization differences between them. GlcNAc and
glucose utilization had a similar alignment and positively
correlated with both components where UMA299 clustered,
which is consistent with its limited ability to utilize HMO
efficiently.
FIGURE 6 | Strain dependent variation of human milk oligosaccharide utilization. Panels (A,C) depict the 2D-principal component analysis (PCA) performed on the
final asymptotic OD600 and the growth rate (k, h
−1) respectively. The arrows in PCA plot represent the correlation of variables with the principal components (PC1 and
PC2). Points represent the scores of each component grouped as biological replicates. The ellipses encompassing each strain capture 68% of the normal probability
of the scores within corresponding strains. Panels (B,D) show the hierarchical clustering dendrogram of strains on the final asymptotic OD600 nm and the growth rate
(k, h−1) using ward method and Euclidean distance. The y-axis measures closeness of either individual strains or clusters. The boxes show the 95% of clustering and
closeness of the strains.
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FIGURE 7 | Growth kinetics of B. longum subsp. infantis strains subsisting on milk carbohydrates. The final asymptotic OD600 nm and growth rate (k, h
−1) of
B. infantis strains while growing on mMRS medium containing 2% (wt/v) galactose (A), lactose (B), lacto-N-tetraose (LNT) (C), and lacto-N-neotetraose (LNnT) (D).
The growth kinetics was calculated with Wolfram Mathematica 10.3 and represents the mean ± SD of three independent experiments. Purple and red bars indicate
bacterial growth and growth rate respectively. The asterisks indicate the significant differences between strains evaluated by one-way ANOVA and Tukey’s multiple
comparison. *p < 0.05, **p < 0.005, ***p < 0.0005, and ****p < 0.0001. The growth kinetics for glucose and GlcNAc were not included as not all strains consume
these monosaccharides.
Hierarchical clustering was employed to determine
quantitative similarities between strains. The height between
the lines indicates the distances between the strains and their
biological replicates (Figure 6B). The PCA and hierarchical
clustering were concordant, and indicated that ATCC 15697 and
UMA301 clustered together with the height of <4 (Figure 6B).
Interestingly, this reflects the phylogenic relationship between
ATCC 15697 and UMA301 (30).
In addition to final biomass achieved, PCA of growth
rates observed on multiple substrates resolved onto PC1 to
encompass 51.6% variability for each strain and positively
correlated with all carbohydrates except lactose (Figure 6C).
This is interesting as Bifidobacterium strains were previously
determined to possess a preference for lactose over glucose (41),
with lactose often used as a positive control and propagation
of bifidobacterial strains. ATCC 15697 and UMA301 co-
clustered and negatively correlated with PC1. These two strains
exhibited similar utilization rates for all substrates tested.
Interestingly, UMA300 growth rates on galactose, LNT, glucose,
and GlcNAc were similar and distinctly clustered from other
strains (Figure 6C) with significantly higher values on these
carbohydrate sources compared to other strains (p < 0.05,
Figure 7). Hierarchical clustering using the Ward method
validated the PCA (Figure 6D). Hierarchical clustering of the
growth rate is also consistent with the same analysis of the
final biomass (OD600 nm, asym), which yielded a similar distance
topology. Accounting for the empirical evidence in aggregate,
B. infantis utilization of LNT and LNnT diverges in a strain-
dependent manner.
B. longum subsp. infantis Strains
Differentially Metabolize Lacto-N-tetraose
and Lacto-N-neotetraose
A comparative analysis of the fermentative endproducts lactic
acid, acetic acid, formic acid, and ethanol was conducted on
the panel of B. infantis strains. These endproducts are secreted
as a result of carbon flux through the F6PPK pathway with
data reported as a heatmap with hierarchical clustering analysis
(Figure 8A). As expected, acetic acid and lactic acid production
clustered more closely with each other than the ethanol and
formic acid production as these two endproducts are secreted
regardless of substrate (Figure 8A).
The metabolic profiling of ATCC 15697 and UMA301 while
fermenting galactose, lactose, and LNT closely clustered together
with high acetic acid and lactic acid and less formic acid and
ethanol produced (Figure 8A). Interestingly, UMA299 produced
higher concentrations of formic acid and ethanol when utilizing
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FIGURE 8 | Analysis of B. longum subsp infantis strains secreted fermentative endproducts while utilizing milk carbohydrates. Panel (A) shows metabolites secreted
by B. infantis strains for each carbohydrate clustered by Euclidean distance calculated with MetaboAnalyst 3.0. The scaling was performed by mean-centering and
dividing by the standard deviation of each metabolite. The red denotes lower concentrations of the metabolite with yellow approaching higher concentrations. Panels
(B,E) display the 2D-principal component analysis (PCA) plot depicting acetic acid to lactic acid ratios and acetic acid to lactic acid to formic acid ratios respectively.
The arrows in PCA plot represent the correlation of the variables with the principal components (PC1 and PC2). Points represent the scores of each component
grouped as biological replicates. The ellipses for each strain incorporate 68% of the normal probability of the scores for corresponding strains. Panels (C,F) are
hierarchical clustering dendrogram of strains according to acetic acid to lactic acid ratios and acetic acid to lactic acid to formic acid ratios using the Ward method
and Euclidean distance. The y-axis measures the closeness of either individual strains or their calculated clusters. Panels (D,G) represent hierarchical clustering based
on p-values calculated with multiscale bootstrapping between acetic acid to lactic acid ratio and acetic acid to lactic acid to formic acid ratio. The y-axis measures the
closeness of either individual substrates or clusters according to two metrics: Approximately Unbiased p-value (AU in red) and Bootstrap Probability value (BP in blue).
Clusters exhibiting AU values >95% are highlighted by rectangles.
GlcNAc, glucose, LNT, and LNnT relative to other carbohydrates
(Figure 8A). This indicates that UMA299 utilizes LNT via a
different metabolic trajectory relative than other strains. This is
consistent with its final biomass and general phenotype as an
atypical HMO consumer (Figure 7C).
ATCC 15697, UMA301, and UMA299 LNnT metabolism
was linked to higher formic acid and ethanol concentrations.
UMA300, in contrast, exhibited a significantly differentmetabolic
profile that is closely linked to LNT with less formic acid and
ethanol production than the other strains (Figure 8A). This
did not differ appreciably from galactose, lactose, and glucose
metabolism. This suggests that UMA300, unlike other strains,
preferentially converts pyruvate to lactic acid rather than acetyl-
CoA regardless of the substrate with the exception of GlcNAc.
The carbon recovery observed in secreted metabolites
after utilization of mono- and di-saccharides are depicted
in Figure S1B. UMA299 recovered almost 100% carbon for
all sugars except galactose. All strains recovered <100%
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FIGURE 9 | Endproduct ratios of B. longum subsp. infantis strain fermentative
endproducts while utilizing the milk carbohydrates. Acetic acid to lactic acid
ratio (A), acetic acid to lactic acid to formic acid ratio (B), and ethanol to lactic
acid ratio (C). Colors indicate the following carbohydrate substrates: Purple,
galactose; red, lactose; dark blue, lacto-N-tetraose; green,
lacto-N-neotetraose. Averages from independent biological replicates (at least
triplicate) are shown with bars representing standard deviation from the mean.
The asterisks indicate the significant differences evaluated by two-way ANOVA
and Tukey’s multiple comparison. *p < 0.05, **p < 0.005, ***p < 0.0005, and
****p < 0.0001.
carbon while fermenting galactose. ATCC 15697, UMA299,
and UMA301 achieved almost 100% carbon recovery while
utilizing lactose. Interestingly, UMA300 exhibited 138% of
carbon recovery as determined by secreted metabolite following
growth on lactose. This was significantly higher than ATCC
15697 and UMA301 (p < 0.05). This might be due to hydrolysis
of the remaining lactose into glucose and galactose in the post-
fermentation medium with UMA300 potentially exhibiting a
preference for utilizing monosaccharides over lactose.
The acetic acid:lactic acid ratios secreted after B. infantis
strains fermented substrates were compared (Figures 8B–D).
Accordingly, PC1 and PC2 encompass 50.7 and 31.2% of the
variation for these ratios (Figure 8B). UMA300 and UMA301
displayed a positive correlation with PC1 whereas ATCC 15697
and UMA299 were negatively correlated. This is due to higher
ratio values of strains on a particular carbohydrate with each
strain clustering distinctly on PC2. The hierarchical clustering of
strains was consistent with the PCA (Figure 8C). This is because
UMA299 showed a significantly higher ratio in both LNT and
LNnT metabolism relative to other strains (p< 0.05, Figure 9A).
In addition, the direction of the LNT and LNnT vectors are
negatively oriented with both components with a highly similar
magnitude and direction in the PCA (Figure 8B). This explains
the close clustering of LNT and LNnT based on Euclidean
distance (<0.95) whereas the HMO carbohydrate constituents
segregated away from both HMO species (Figure 8D). The
agglomerative clustering of strains revealed no differences for
LNT and LNnT. This is potentially due to GlcNAc deacetylation
increasing acetic acid production during HMO utilization.
Formic acid production underlies divergent mechanisms for
LNT and LNnT metabolism (Figures 8E–G). Accordingly, the
PCA performed on the acetic acid:lactic acid:formic acid ratios
clearly indicates that LNT and LNnT fermentation proceeds
via distinctive metabolic routes as these vectors are oriented
in opposing directions along PC1 (captures 52.0% variation)
(Figure 8E). This suggests that B. infantis strains shunt LNnT
catabolism toward conversion of pyruvate to acetyl-CoA rather
than lactic acid to subsequently secrete formic acid.
UMA300 was positively positioned along PC1 whereas
ATCC 15697 and UMA301 were primarily explained by
PC2. Interestingly, ATCC 15697 and UMA301 do not cluster
together as depicted in Figure 8F despite exhibiting phenotypic
and phylogenetic similarities. However, if the significance of
height in the hierarchical clustering is increased, they cluster
together, and only UMA300 stands alone. This is due to
UMA300 not significantly secreting formic acid except during
GlcNAc fermentation (Figure 8A). B. infantis ATCC 15697 and
UMA301 produced significantly more formic acid during LNnT
fermentation than LNT that resulted in a decrease of the ratio
(p< 0.05, Figure 9B).
The ethanol to lactic acid ratio was dependent on the
carbohydrate source and strain (Figure 9C). UMA300 did not
produce ethanol regardless of the substrate whereas UMA299
exhibited a higher ratio for both LNT and LNnT relative to
other strains (p < 0.05). Interestingly, UMA301 had limited
ethanol production during LNT fermentation while the ratio
increased in LNnT utilization. This means that all strains
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except UMA300 utilize LNnT along a similar metabolic route.
Thus LNnT utilization by ATCC 15697 and UMA301 might
involve NAD+ regeneration through ethanol production whereas
recycling NAD+ during LNT utilization most likely occurs as
pyruvate is converted to lactic acid.
Human Milk Carbohydrate Utilization
Mitigates Lipopolysaccharide-Induced IL-8
Expression in Caco-2 Epithelial Cells
It is known that metabolism of specific carbohydrates may
influence bifidobacterial interactions with intestinal epithelia
under certain conditions. Pooled HMO-grown bifidobacteria
reduce inflammatory markers compared to glucose or lactose-
grown bifidobacteria (53, 54). These previous studies examined
adhesive properties of bifidobacteria and bacterial translocation
in exponential growth instead of cell-free supernatants collected
at stationary phase. Differential metabolism of LNT and
LNnT inspired the hypothesis that host-microbial interactions
may be influenced in a milk oligosaccharide-dependent
manner. In order to address this, metabolites present in
spent media subsequent to B. infantis growth on lactose,
LNT, and LNnT were evaluated for their ability to mitigate
inflammation. Specifically, it was hypothesized that higher
acetic acid and formic acid concentrations secreted from LNnT
metabolism will differentially influence inflammation. Gene
expression of the cytokine marker of inflammation IL-8 was
measured in Caco-2 cells following lipopolysaccharide-induced
inflammation (Figure 10). Accordingly, spent media from
all three fermentations significantly reduced IL-8 expression
compared with the negative control (p < 0.05). However,
there was no significant difference between the three milk
carbohydrates. In addition, the markers of inflammation IL-10
and TNF-α were assayed and yielded inconsistent and thus
inconclusive results. Although B. infantis metabolism of these
human milk carbohydrates protects against inflammation, it is
unclear to what extent that B. infantis alone is responsible for
the anti-inflammatory effect. In addition, purified acetic acid,
lactic acid, and formic acid were tested, however, the results were
inconclusive due to variation between biological replicates.
DISCUSSION
Bifidobacterium longum subsp. infantis evolved to utilize
glycans secreted in human milk to generate ATP as well
as provide substrates for anabolic processes. Accordingly, its
genome incorporates a 40-kb locus dedicated to human milk
oligosaccharide utilization that is conserved in all B. infantis
strains isolated to date (10, 30). The activities encoded
by the HMO gene cluster allocate degradation products
to be further metabolized prior to entering the F6PPK
pathway, the characteristic fermentative pathway unique to
the Bifidobacterium genus (20). HMOs evade digestion during
gastrointestinal tract transit and thus are available to B. infantis
to translocate intracellularly (16, 29). The F6PPK pathway
terminates invariably in the extracellular secretion of acetic acid
and lactic acid, with formic acid and ethanol generated to a
FIGURE 10 | Gene expression of inflammatory marker Interleukin-8 in Caco-2
epithelial cells exposed to spent media following milk oligosaccharide
fermentation. The y-axis represents the fold change in IL-8 expression relative
to phosphate buffer solution (PBS). The x-axis depicts the sources of
B. infantis metabolites which are used to treat Caco-2 cells after
lipopolysaccharides (LPS) induction. The error bars show standard deviations
of biological duplicates, each measured with three technical replicates. The
single asterisks (*) indicate the significant differences evaluated by one-way
ANOVA and Tukey’s multiple comparison (p < 0.05).
lesser extent under specific conditions (20–23). The potential
for B. infantis to differentially metabolize purified HMO species
has not been fully tested. The HMO tetrasaccharides LNT and
LNnT differ by a β1-3 and β1-4 linkage between galactose and
N-acetylglucosamine at the non-reducing terminus respectively.
Accounting for this structural variance, we hypothesized that
LNT and LNnT are differentially metabolized after initiating
distinct transcriptomic cascades to process these HMOs.
Previous research conducted on B. infantis provided the
preliminary observations to generate this hypothesis (17, 26). In
this current study, the model HMO-consuming strain B. infantis
ATCC 15697 exhibits higher growth efficiency (i.e., asymptotic
final OD) while metabolizing LNT rather than LNnT. This
occurred in the absence of a preference for LNT over LNnT
extrapolated from their similar growth rates. Thus ATCC 15697
may experience enhanced fitness when encountering LNT in
the infant gut, although this remains to be tested in an in vivo
system. Moreover, ATCC 15697 diverges in the metabolic fate
of carbons during LNT or LNnT utilization. The ratio of
secreted acetic acid to lactic acid (AA:LA) is considerably higher
for LNT and LNnT than other carbohydrates. Importantly,
LNnT promotes a significantly higher AA:LA ratio relative to
LNT. The deacetylation of GlcNAc via deacetylase activity (EC
3.5.1.25, Figure 3) likely contributes to the increase in relative
concentrations of acetic acid during LNT metabolism.
Of particular importance is that LNnT metabolism
significantly increases formic acid production. This is not
observed during LNT metabolism and constitutes a major
metabolic shift solely attributable to the isomeric composition
of LNnT. Thus the AA:LA ratio increases during LNnT
fermentation likely due to GlcNAc deacetylation and a
simultaneous decrease in lactic acid in shunting pyruvate
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toward formic acid production. The conversion of pyruvate
to acetyl-CoA and subsequently to acetic acid during LNnT
utilization results in formic acid and ethanol production.
Modulation of acetic acid production produces higher levels
of ATP during LNnT fermentation. This is consistent with the
relative inefficiency LNnT is utilized for biomass as limited
ATP restricts cellular growth. Bifidobacteria are known to
increase formic acid secretion during inefficient metabolism
of unfavorable substrates (25, 50, 55–57). It is noteworthy that
previous studies observed cellular growth considerably lower
than the accumulated biomass generated on LNnT in the present
study.
In addition, increased ethanol production during LNnT
metabolism recycles NAD+ following reduction of acetyl-coA.
Since formic acid is generated at the expense of lactic acid,
recovering NAD+ is critical as lactic acid production recycles
cofactors and does not yield ATP (23). On a molar basis the
2-carbon pathway terminating in ethanol recoups double the
amount of NAD+ than the 3-carbon arm (i.e., pyruvate to lactic
acid). Whereas it is clear that LNnT shifts metabolism toward
formic acid and ethanol production, the molecular mechanisms
underlying these alternative pathways remains incompletely
understood. It is clear, however, that the terminal β1-4 linkage
in LNnT prompts this divergent physiological response.
In an effort to determine the contribution of global gene
expression to LNT and LNnT metabolism, previously generated
RNA-seq data was analyzed in addition to targeting key loci
with qRT-PCR. A previous study of Bifidobacterium breve
UCC2003 concluded that there are overlapping metabolic
transcriptional networks with some critical features that are
unique between LNT and LNnT metabolism (58). It is
noteworthy that B. breve evolved the capacity to hydrolyze
HMO extracellularly and imports degradation products. There is
limited evidence that B. infantis is able to do so, which indicates
a fundamental physiological difference between the two species.
As B. infantis captures HMO from its extracellular environment,
the complement and expression of transport proteins may
catalyze or restrict metabolism of a given HMO species. In
this study, the F1SBP Blon_2347 expression differed between
the two HMO species, whereas Blon_2177 and Blon_2344 were
expressed regardless of the specific HMO. Interestingly, the
global transcriptome exhibited a different expression profile for
these particular genes. Additional studies are required to resolve
the conflict between expression of transporters predicted to be
active on type I glycans (i.e., LNT) (16) that were observed to
be induced by the type II LNnT. Further characterization of
the functional interactions between transport systems and HMO
substrates may be essential to address these discrepancies.
The aminosugar residue GlcNAc is a constituent of LNT,
LNnT, and all HMOs with a degree of polymerization ≥4. Prior
to entering the F6PPK pathway, GlcNAc is processed by two
enzymes putatively encoded within the ATCC 15697 genome.
This includes GlcNAc-6-P deacetylase (nagA; Blon_0882) that
deacetylates GlcNAc prior to deamination by glucosamine-6-P
isomerase (nagB; Blon_0881). B. infantis expresses both of these
proteins when grown on pooled HMO as reported in a previous
study (51). In this study, both LNT and LNnT upregulated
these loci supporting the postulate that HMO-bound GlcNAc
metabolism contributes to skewing the AA:LA ratio. The elevated
AA:LA ratio was observed for pooled HMOs and LNT in a
previous study that focused primarily on galactooligosaccharides
(47). It is important to note that GlcNAc-bound in HMO may
not be fully catabolized through the F6PPK pathway as GlcNAc
could serve as a substrate in anabolism including peptidoglycan
and other biosynthetic processes (17). Interestingly, ATCC 15697
does not utilize GlcNAc when supplied as sole carbon source
in the media in contrast to other B. infantis strains. This may
be due to a genetic or regulatory variation inherent to the
strain. Moreover, hexosaminadase genes were expressed similarly
regardless of the particular HMO isomer. These enzymes liberate
GlcNAc from galactose through hydrolyzing the β1-3 linkage
that is present in both LNT and LNnT.
The terminal galactose, contrastingly, is connected to GlcNAc
via a β1-3 linkage in LNT and a β1-4 linkage in LNnT. Thus it was
unexpected that a type I glycan-active (e.g. LNT) β-galactosidase
(Blon_2016) is downregulated by LNT and not LNnT (p < 0.05)
(52). This may be due to constitutive expression of other
β-galactosidases that cleave the terminal galactose in vivo. It
is significant that both HMO isomers upregulate two genes
that are predicted to feed galactose into the F6PPK pathway.
This includes gal-1-P uridylyltransferase (galT; Blon_2172) and
Uridine 5′-diphospho-glucose-4-epimerase (UDP-glc epimerase,
galE; Blon_2171) that are localized adjacent to HMO transporters
on the ATCC 15697 chromosome. Furthermore, LNnT induces
these genes to a greater extent than LNT. This provides
mechanistic detail for the physiological differences between
LNnT and LNT fermentation.
Interestingly, LNT and LNnT upregulates α-L-fucosidase
gene expression despite lacking fucosyl moieties within their
respective oligosaccharide structure. Accordingly, LNT strongly
upregulates two fucosidases localized to the HMO catabolic
cluster. This suggests that there is overlapping regulatory
systems or B. infantis recognizes LNT and LNnT as signaling
molecules to prepare for metabolizing fucosylated HMOs. HMO
tetrasaccharides is utilized early in fermenting pooled HMOs
prior to fucosylated glycans (19).
Constituent monosaccharides bound in HMO are
transformed into substrates catabolized through the F6PPK
pathway. Accordingly, LNnT upregulates several genes in this
central metabolic pathway likely to satisfy energy demands
from a more inefficiently metabolized oligosaccharide. It is
interesting that both acetate kinase and lactate dehydrogenase
are upregulated by LNnT relative to LNT or lactose. The former
is expected given the physiological evidence for increased acetic
acid secretion. Lactate dehydrogenase upregulation may be a
consequence of fully activating a central metabolic regulon to
maintain NAD+/NADH homeostasis. There is a significant
link between formic acid production and transcriptional
processes. LNnT strongly induces formate acetyl transferase
(pfl; EC 2.3.1.54), which catalyzes formic acid and acetyl-CoA
production from pyruvate. In contrast, LNT downregulates this
gene as well as pyruvate formate lyase, the latter of which appears
to be constitutively expressed during LNnT fermentation. This
represents a strong mechanistic association between the LNnT
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structure and B. infantis genomic features to drive the metabolic
phenotype.
As bacterial strains of a given taxon may exhibit profoundly
dissimilar phenotypes, three additional B. infantis strains
were examined. B. infantis UMA301 exhibits a very similar
metabolic response to LNT and LNnT relative to ATCC
15697. Interestingly, these two strains are closely related
phylogenetically (30), which suggests that metabolic signature
may be a function of phylogenetic divergence for B. infantis
HMOutilization. Similarly to ATCC15697, LNnT shifts UMA301
metabolism toward formic acid and increases the ratio of acetic
acid to lactic acid secretion.
In contrast, UMA300 efficiently utilizes both LNnT and
LNT and does not produce formic acid and ethanol on either
substrate to the same extent as ATCC 15697 and UMA301.
This is likely a function of UMA300 processing LNnT in a
efficient manner as LNT, which obviates the need for a metabolic
shift. The inefficient HMO-consumer UMA299 exhibits a
metabolic response congruent with this unique phenotype
among B. infantis examined to date (30). The limited capacity
to utilize HMO has been attributed to genetic defects within
its HMO genomic cluster and provides a control strain linking
genotype with metabolic phenotypes. As a result of inefficient
growth on LNT and LNnT, UMA299 increases the AA:LA
ratio, and formic acid/ethanol production. This is consistent
with the hypothesis that diminished capacity for utilizing HMO
promotes higher acetic acid concentrations compared to other
carbohydrates despite achieving low optical density.
A cell culture approach was used to further develop
a model of host-microbial interactions that incorporates
inefficient metabolism of specific HMOs. Cell-free supernatants
from B. infantis HMO fermentations were evaluated for
their anti-inflammatory properties on Caco-2 cells. Given
the parameters tested, it appears that B. infantis reduces
inflammation regardless of milk carbohydrate source. Specific
anti-inflammatory molecules presented or secreted by B. infantis
remains hypothetical. Moreover, the extent to which other HMO
structures diminish inflammatory outcomes is not understood.
In conclusion, LNT and LNnT utilization increased the AA:LA
ratio in all strains. In instances where LNT or LNnT was
inefficiently utilized, carbon was shunted toward formic acid
and ethanol secretion. A fully integrated mechanistic model
underlying this phenotype remains incompletely developed.
Thus there is a scientific need to investigate all purified
HMO species, additional B. infantis strains, as well as other
bifidobacterial species to ascertain linkages between HMO
structure and physiological responses. This will further refine the
metabolic model by which bifidobacteria utilize HMO to colonize
the nursing infant colon. In addition to fundamental biological
research, there are broad implications to infant nutrition
and health. There is accumulating evidence that rationally
designing interventions to enhance infant nutrition will require
judicious selection of HMOs. This could involve incorporating
a single HMO species or a mixture. Clearly a specific HMO
tetrasaccharide has different metabolic consequences depending
on the B. infantis population. There is the potential for
strain-level effects to influence the emergent properties of the
infant gut microbiome community. Accounting for variation
between bifidobacteria, HMO structures, the biology of the
infant, and their hosted microbiome communities may enable
delivery of precision nutrition and increase impact of the
intervention.
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